95. Lefebvre R. C., Rochlin L. Social marketing. В кн.: Glanz K., Lewis F. M., Rimer B. K. Health behavior and health education. Theory, Research and Practice / 2nd edition. Jossey-Bass Publishers San Francisco. - 1997. – P. 384-402.
96. Leinweber CE, Macdonald JM, Campbell munity smoking cessation contests: an effective public health strategy. Cancer Prevention Program, Alberta Cancer Board, Calgary // Can J Public Health. - 1994 Mar-Apr. – Vol. 85(2). – P. 95-98.
97. Levin ML, Goldstein H, Gerhardt PR. Cancer and tobacco smoking // JAMA. – 1950. Vol. 143. – P. 336-338.
98. Levin ML. The occurrence of lung cancer in man // Acta-Unio Internationalis Contra Cancrum. - 1953. - Vol. 9. – P. 531-541.
99. Lichtenstein E., Glasgow RE. Smoking cessation: what have we learned over the past decade? // Journal of Consulting and Clinical Psychology. - 1992. Vol. 60(4). – P. 518-527.
100. Liu B-Q, Peto R, Chen Z-M et al. Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths // BMJ. – 1998. – Vol. 317. – P. 1411-1422.
101. Lopez A. Tobacco is unique in its killing ability. Smokefree Europe. A Forum for Networks. Key Trends for 2000 and beyond. Conference on Tobacco or Health / Helsinki, Finland, 1996, 2-4 October. - P. 122-128.
102. McGuire WJ. Attitudes and attitude change. In: Lindszey G, Aronson E. The Handbook of Social Psychology / Vol II, 3rd Ed. Random House, New York, P. 233-246.
103. Mills CA, Porter MM. Tobacco smoking habits and cancer of the mouth and respiratory system // Cancer Res. – 1950. – Vol. 10. – P. 539-542.
104. Montano D. E., Kasprzyk D., Taplin S. H. The theory of reasoned action and the theory of planned behavior. В кн.: Glanz K., Lewis F. M., Rimer B. K. Health behavior and health education. Theory, Research and Practice / 2nd edition. Jossey-Bass Publishers San Francisco. - 1997. – P. 85-112.
105. Mudde AN, De Vries H. Reach and effectiveness of a national mass media-led smoking cessation campaign in the Netherlands // American Journal of Public Health. – 1999. Vol. 89(3). P. 346-350.
106. Murray, C. J.L. & Lopez, A. D. (eds). In The global burden of disease / Harvard School of Public Health, Boston, Massachusetts. - 1996.
107. Niu S-R, Yang G-H, Chen Z-M et al. Emerging tobacco hazards in China: 2. Early mortality results from a prospective // BMJ. – 1998. – Vol. 317. – P. 1423-1424.
108. O’Brien B. Principles of economic evaluation for health care programs // The Journal of Rheumatology. – 1995. – Vol. 22. - P. 1399-1402.
109. O’Byrne D. Курение в Европе / Сб. научн. тр.: Профилактика неинфекционных болезней: опыт и перспективы / Отв. ред. - ВОЗ, Женева, 1991. - С. 127-138.
110. Petitti D. B. Economic evaluation. In: Applied Epidemiology. R. C.Brownson, D. B.Petitti. Oxford University Press. – 1998. - P. 277-298.
111. Peto R, Chen Z-M, Boreham J. Tobacco-the growing epidemic // Nature Medicine. – 1999. – Vol. 5(1). – P. 15-17.
112. Peto R, Darby S, Deo H et al. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies // British Medical Journal. – 2000, August 5. – Vol. 321 (7257). – P. 323-329.
113. Peto R, Lopez AD, Boreham J et al. Mortality from smoking in developed countries 1950-2000: indirect estimates from national vital statistics // Lancet. – 1992 May 23. – Vol. 339(8804). – P. 1268-1278.
114. Peto R, Lopez AD, Boreham J et al. Mortality from smoking in developed countries: indirect estimates from national vital statistics // The Lancet. – 1992. – Vol. – 339. – P. 1268-1278.
115. Peto R, Lopez AD, Boreham J et al. Mortality from smoking worldwide // British Medical Bulletin. – 1996. – Vol. 52(1). – P. 12-21.
116. Phillips C, Health Economics University of Wales, Swansea, Thompson G, What is a QALY? / Hayward Medical Communications. - 1998, June, www. evidence-based-medicine. co. uk .
117. Phillips C, Health Economics University of Wales, Swansea, Thompson G, What is a cost-effectiveness? / Hayward Medical Communications. - 2001, V 1, No 3 www. evidence-based-medicine. co. uk .
118. Prochaska J. O., Redding C. A., Evers K. E. The Transtheoretical model and stages of change. В кн.: Glanz K., Lewis F. M., Rimer B. K. Health behavior and health education. Theory, Research and Practice / 2nd edition. Jossey-Bass Publishers San Francisco. - 1997. – P. 60-84.
119. Prochaska JO, Velicer WF, DiClemente, Fava J. Measuring processes of change: Applications to the cessation of smoking // Journal of Consulting and Clinical Psychology. – 1988. – Vol. 56. – P. 520-528.
120. Prochaska JO. A stages paradigm for integrating clinical and public health approaches to smoking cessation // Addictive Behaviors. – 1996. – Vol. 21(6). – P. 721-732.
121. Prokhorov A. Getting on Smokin’Route 66: tobacco promotion via Russian mass media // Tobacco Control. – 1997. – Vol. 6. – P. 145-146.
122. Puska P, Korhonen H, Uutela A. et al. Anti-smoking policy in Finland. Smokefree Europe. A Forum for Networks. Conference on Tobacco or Health. Helsinki, Finland 2-4 October, 1996. P. 26-45.
123. Puska P, Korhonen HJ, Korhonen T, McAlister A. International Quit and Win ’96: a global campaign to promote smoking cessation // Tobacco Control. – 1996. – Vol. 5. – P. 342-347.
124. Puska P, Matilainen T, Jousilahti P et al. Cardiovascular risk factors in the Republic of Karelia, Russia and in North Karelia, Finland // Int. J of Epid. – 1993. – Vol. 22, #6. - P. 1048-1055.
125. Puska P, Nissinen A, Tuomilehto J et al. The community-based strategy to prevent coronary heart disease: conclusions from the ten years of the North Karelia Project // Annual Review of Public Health. – 1985. – Vol. 6. – P.147-193.
126. Puska P., Tuomilehto J., Nissinen A., Vartiainen E. The North Karelia Project 20 Year Results and Experience / National Public Health Institute, KTL Helsinki, 1995. – P. 221-223.
127. Puska P., Tuomilehto J., Nissinen A., Vartiainen E. The North Karelia Project 20 Year Results and Experience / National Public Health Institute, KTL Helsinki, 1995. – P. 159-167.
128. Puska P., Vartiainen E. Heart Disease: the lifestyle killer. In: The evidence of Health Promotion Effectiveness, part two. ECSC-EC-EAEC, Brussels-Luxembourg. – 2000. - P. 55-68.
129. Ranson MK, Jha P, Chaloupka FJ, Nguyen SN. Global and regional estimates of the effectiveness and cost-effectiveness of price increases and other tobacco control policies // Nicotine & Tobacco Research. – 2002. – Vol. 4. – P. 311-319.
130. Ratcliffe J, Cairns J, Platt S. Cost effectiveness of a mass media-led anti-smoking campaign in Scotland. Health Economics Research Group, Brunel University, Uxbridge, Middlesex, UK // Tobacco Control. - 1997. – Vol. 6(2). – P. 104-110.
131. Redman S, Spencer EA, Sanson-Fisher RW. The role of mass media in changing health-related behavior: a critical appraisal of two models // Health Promotion International. – 1990. – Vol. – 5. - P. 85-101.
132. Reducing Tobacco Use. A report of the Surgeon General / Atlanta, Georgia: U. S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. - 2000. – P. 97-101.
133. Reducing Tobacco Use. A report of the Surgeon General / Atlanta, Georgia: U. S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. - 2000. – P. 8-11.
134. Roberts C, Smith C, Catford J. Quit and Win Wales: an evaluation of the 1990 pilot contest // Tobacco control. – 1993. Vol. 2. – P. 114-119.
135. Russell LB, Gold MR, Siegel JE et al. The role of cost-effectiveness analysis in health and medicine // JAMA. – 1996. – Vol. 276. – P. 1172-1177.
136. SAMMEC 3.0 Smoking-attributable mortality, morbidity and economic puter Software and Documentation. Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Public Health Service, U. S.Department of Health and Human Services. 2004. - http://apps. nccd. cdc. gov/sammec/ .
137. Sans S., Kesteloot H., Kromhout D. on behalf of the Task Force “Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe // European Heart Journal. – 1997. – Vol. 18. – P. 1231-1248.
138. Schooler C, Farquhar JW, Fortmann SP, Flora JA. Synthesis of findings and issues from community prevention trials // Ann. Epidemiol. - 1997. – Vol. S7. – P. 54-68.
139. Schrek R, Baker LA, Ballard GP, Dolgoff S. Tobacco smoking as an etiologic factor in disease // Cancer Res. – 1950. – Vol. 10. – P. 49-58.
140. Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations for reporting cost-effectiveness analyses // JAMA. - October 23/30, 1996. – Vol. 276 (16). – P. 1339-1341.
141. Steenkamp HJ, Jooste PL, Jordaan PCJ et al. Changes in smoking during a community-based CVD intervention programme: the Coronary Risk Factor Study // South African Medical Journal. – 1991. Vol. 79(5). – P.250-253.
142. Strecher V. J., Rosenstock I. M. The health belief model. В кн.: Glanz K., Lewis F. M., Rimer B. K. Health behavior and health education. Theory, Research and Practice / 2nd edition. Jossey-Bass Publishers San Francisco. - 1997. – P. 41-59.
143. Targeting tobacco use: the nation’s leading cause of death. At-a-glance / U. S.Department of Health and Human Services, CDC, Atlanta, GA, USA. - 1999. – P. 1-6.
144. Tengs TO, Adams ME, Pliskin JS et al. Five-hundred life saving intervention and their cost-effectiveness // Risk analysis. – 1995. - Vol. 15, No 3. – P. 69-390.
145. The Catalonia Declaration. Investing in heart health. The 2nd International Heart Health Conference, Barcelona / Catalonia (Spain), 1995. - June 1. – P. 5-52.
146. The Lipid Research Clinics Population. Studies Data Book. Volume IY. The USSR Second Prevalence Study / U. S. Department of Health and Human Services Public Health Service National Institute of Health, 1990. June. 31 p.
147. The Osaka Declaration Health, Economics and Political Action: Stemming the Global Tide of Cardiovascular Disease. The 4th International Heart Health Conference / Osaka (Japan), 2001. – May. – P. 11-38.
148. Thorndike AN, Rigotti NA, Stafford RS, Singer DE. National patterns in the treatment of smokers by physicians // JAMA. - February 25, 1998. – Vol. 279. - No 8. – P. 604-608.
149. Tillgren P, Haglund BJ, Ainetdin T, Holm LE. Who is a successful quitter? One-year follow-up of a National Tobacco Quit and Win Contest in Sweden. Karolinska Institute, Department of International Health and Social Medicine, Kronan, Sundbyberg, Sweden // Scand J Soc Med. - 1995 Sep. – Vol. 23(3). – P. 193-201.
150. Tillgren P, Haglund BJA, Gilljam H, Holm L-E. A tobacco quit and win model in the Stockholm Cancer prevention Program // European Journal of Cancer Prevention. – 1992. – Vol. 1. – P. 361-366.
151. Tillgren P, Rosen M, Haglund BJ, Ainetdin T, Lindholm L, Holm LE. Cost-effectiveness of a tobacco 'Quit and Win' contest in Sweden. Kronan Health Centre, Sundbyberg, Sweden // Health Policy. – 1993 Nov. – Vol. 26(1). – P. 43-53.
152. Tsevat J. Impact and cost-effectiveness of smoking interventions.
Department of Medicine, Beth Israel Hospital, Harvard Medical School, Boston, Massachusetts // Am J Med. - 1992 Jul. – Vol. 15;93(1A). – P. 43S-47S.
153. Vartiainen E, Korhonen HJ, Koskela K, Puska P. Twenty year smoking trends in a community-based CVD prevention programme: results from the North Karelia Project // European Journal of Public health. – 1998. – Vol. 8(2). – P.154-159.
154. Warner KE. Smoking cessation: alternative strategies: financing implications // Tobacco control, Autumn, 1995.
155. Winkleby A, Flora JA, Kraemer HC. A community-based heart disease intervention: predictors of change // American Journal of Public health. - 1984. – Vol. 5. – P. 767-772.
156. Women and the tobacco epidemic. Challenges for the 21st Century. WHO in collaboration with the Institute for Global Tobacco Control Johns Hopkins School of Public Health / Edited by Jonathan M. Samet, Soon-Young Yoon. 2001. – P. 23-31.
157. Wynder EL, Graham EA. Tobacco smoking as a possible etiologic factor in bronchogenic carcinoma // JAMA. – 1950. Vol. 143. – P. 329-336.
158. Zatonski WA, Jha P. The health transformation in Eastern Europe after 1990: a second look / The M. Skladowska-Curie Memorial Cancer Center and Institute of Oncology. Warszawa, Poland, 2000. – P. 39-43.
|
Из за большого объема этот материал размещен на нескольких страницах:
1 2 3 4 5 6 7 8 |


